What is the market doing?
What the tape says about ONC
BeOne Medicines AG is +26% over the past year while the S&P 500 is +23%: 3.5 points ahead of the market.
+26%
1-year return · S&P 500 +23%
- vs 200-day average
- +18%
vs 200-day average · a clear uptrend
- RSI (14)
- 75
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.40%
Below its 52-week high
Details›
- Last close2026-08-26
- $375.97
- 1 monthS&P 500 +3.7%
- +15%
- 1 yearS&P 500 +23%
- +26%
- 5 yearsS&P 500 +87%
- +15%
- vs 50-day average$313.44
- +20%
- 52-week high
- $377.47
- 52-week low
- $260.27
- Annualised volatility
- 43%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$7.5M
| Year | Return |
|---|---|
| 2026 (year to date) | +24% |
| 2025 | +64% |
| 2024 | +2.4% |
| 2023 | −18% |
| 2022 | −19% |
| 2021 | +4.9% |
| 2020 | +56% |
| 2019 | +18% |
| 2018 | +44% |
| 2017 | +222% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +8.4% |
| Feb | 10 | 6 of 10 | +2.8% |
| Mar | 10 | 3 of 10 | −3.2% |
| Apr | 10 | 4 of 10 | +2.6% |
| May | 10 | 3 of 10 | −2.3% |
| Jun | 10 | 4 of 10 | +0.26% |
| Jul | 11 | 9 of 11 | +15% |
| Aug | 11 | 7 of 11 | +4.4% |
| Sep | 10 | 6 of 10 | +7.0% |
| Oct | 10 | 5 of 10 | −0.45% |
| Nov | 10 | 6 of 10 | +6.4% |
| Dec | 10 | 3 of 10 | −4.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #58 of 145 by Smart Score